P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure

Saved in:

Bibliographic Details
Main Authors:	Fred Poordad (Author), Stanislas Pol (Author), Armen Asatryan (Author), Maria Buti (Author), David Shaw (Author), Christophe Hézode (Author), Franco Felizarta (Author), Robert W. Reindollar (Author), Stuart C. Gordon (Author), Stephen Pianko (Author), Michael W. Fried (Author), David E. Bernstein (Author), Joel Gallant (Author), Chih-Wei Lin (Author), Yang Lei (Author), Teresa I. Ng (Author), Tami Pilot-Matias (Author), Jens Kort (Author), Federico Mensa (Author)
Format:	Book
Published:	Elsevier, 2017-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet

Holdings details from 3rd Floor Main Library
Call Number:	A1234.567
Copy 1	Available